AP9801368A0 - Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection - Google Patents
Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infectionInfo
- Publication number
- AP9801368A0 AP9801368A0 AP9801368A AP9801368A AP9801368A0 AP 9801368 A0 AP9801368 A0 AP 9801368A0 AP 9801368 A AP9801368 A AP 9801368A AP 9801368 A AP9801368 A AP 9801368A AP 9801368 A0 AP9801368 A0 AP 9801368A0
- Authority
- AP
- ARIPO
- Prior art keywords
- hiv
- mentia
- infection
- aids virus
- benzamide treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1571096P | 1996-04-17 | 1996-04-17 | |
PCT/US1997/006351 WO1997038684A1 (en) | 1996-04-17 | 1997-04-17 | Benzamide treatment of dementia associated with aids virus (hiv-1) infection |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9801368A0 true AP9801368A0 (en) | 1998-12-31 |
AP898A AP898A (en) | 2000-11-17 |
Family
ID=21773101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1998/001368A AP898A (en) | 1996-04-17 | 1997-04-17 | Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0912171A1 (en) |
CN (1) | CN1218399A (en) |
AP (1) | AP898A (en) |
AU (1) | AU720578B2 (en) |
BR (1) | BR9708720A (en) |
CA (1) | CA2252403A1 (en) |
IS (1) | IS4868A (en) |
NZ (1) | NZ332438A (en) |
OA (1) | OA10901A (en) |
TW (1) | TW412421B (en) |
WO (1) | WO1997038684A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1482909B1 (en) | 2002-02-13 | 2018-07-04 | Creagri, Inc. | Method and composition for treatment of inflammation |
JP6750177B2 (en) * | 2015-12-11 | 2020-09-02 | ロート製薬株式会社 | Anthranilamide derivative and therapeutic agent for diseases involving TLR3 containing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5472983A (en) * | 1994-04-14 | 1995-12-05 | Centaur Pharmaceuticals, Inc. | Benzamide-containing pharmaceutical compositions |
IL117629A (en) * | 1995-04-03 | 2000-08-13 | Centaur Pharmaceuticals Inc | Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof |
-
1997
- 1997-04-17 WO PCT/US1997/006351 patent/WO1997038684A1/en not_active Application Discontinuation
- 1997-04-17 TW TW86104991A patent/TW412421B/en active
- 1997-04-17 BR BR9708720-3A patent/BR9708720A/en not_active Application Discontinuation
- 1997-04-17 CN CN 97194582 patent/CN1218399A/en active Pending
- 1997-04-17 AP APAP/P/1998/001368A patent/AP898A/en active
- 1997-04-17 CA CA 2252403 patent/CA2252403A1/en not_active Abandoned
- 1997-04-17 NZ NZ332438A patent/NZ332438A/en unknown
- 1997-04-17 AU AU27322/97A patent/AU720578B2/en not_active Ceased
- 1997-04-17 EP EP97921220A patent/EP0912171A1/en not_active Ceased
-
1998
- 1998-10-16 IS IS4868A patent/IS4868A/en unknown
- 1998-10-16 OA OA9800198A patent/OA10901A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2732297A (en) | 1997-11-07 |
CN1218399A (en) | 1999-06-02 |
OA10901A (en) | 2002-02-14 |
WO1997038684A1 (en) | 1997-10-23 |
EP0912171A1 (en) | 1999-05-06 |
AP898A (en) | 2000-11-17 |
TW412421B (en) | 2000-11-21 |
NZ332438A (en) | 2001-02-23 |
IS4868A (en) | 1998-10-16 |
CA2252403A1 (en) | 1997-10-23 |
BR9708720A (en) | 2000-01-04 |
AU720578B2 (en) | 2000-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0831873A4 (en) | The treatment of hiv and other viral infections using combinatory therapy | |
AP9901661A0 (en) | Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases | |
HK1060847A1 (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection | |
PL344223A1 (en) | Compositions for the treatment of hiv and other viral infections | |
CA2072573A1 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
EP1034003A4 (en) | Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy | |
NZ310055A (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection | |
AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
NZ307494A (en) | Lymphokine capable of inhibiting immunodeficiency viruses | |
AU4088697A (en) | Postinfection human immunodeficiency virus (hiv) vaccination therapy | |
GB9304746D0 (en) | Treatment of viral infections | |
HK1050011A1 (en) | Treatment of viral infections using levovirintm | |
HK1044896A1 (en) | Method of treating hiv infection and related secondary infections thereof | |
EE03514B1 (en) | A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition | |
AU4602897A (en) | Method for treatment of immunodeficiency virus infection | |
AP9801368A0 (en) | Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection | |
AU3530395A (en) | Treatment of viral infections | |
NO965591D0 (en) | Combination treatment of HIV infection | |
IL130160A0 (en) | Inactivation of HIV co-receptors as therapy for HIV infection | |
AU3593095A (en) | Method of treatment of human immunodeficiency virus (hiv) infection | |
EP0960216A4 (en) | Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt | |
AU9495098A (en) | Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection | |
OA09648A (en) | Immunotherapeutic compositions for treating and preventing AIDS ARC and HIV infection | |
EP0949915A4 (en) | Nitrone free radical trap treatment of dementia associated with aids virus (hiv-1) infection |